Coca-Cola Helps Suja Pour It On

JUICE: Investment Boosts Co.’s Capacity, But Doesn’t Change Its Philosophy

Suja Life LLC’s first commercial juice press, a blue machine about the size of a minifridge, still stands on the floor of its Oceanside production facility. But nearby is the real powerhouse: a German-made Flottweg belt press with the ability to squeeze nearly all of the juice from the produce it mashes.

Tease photo

Sophiris Bio Borrows $7M to Extend Its Runway, Conduct Trials

La Jolla-based Sophiris Bio Inc. has borrowed $7 million from Silicon Valley Bank to help finance late stage clinical trials and to extend the company’s cash runway through 2019.

RF Industries Reports $7.8M in Net Sales for Q3

San Diego-based RF Industries Ltd. reported net income of $192,000 or 2 cents per share on net sales of $7.8 million in its third quarter, which ended July 31.

Ionis Subsidiary Seeks OK to Sell Drug in Canada

Akcea Therapeutics, a spinout and subsidiary of Carlsbad drugmaker Ionis Pharmaceuticals, has asked for the green light from regulators to sell one of its drugs in Canada.

Lytx Moving Manufacturing From China to Indiana

Lytx said it plans to move manufacturing for its DriveCam video event recorders from mainland China to Indiana.

Zavante Teaming With NIH to Try and Crush Deadly Bug

Local biotech Zavante Therapeutics is teaming up with the National Institutes of Health to see if its antibiotic will fight nasty infections acquired in hospitals.

Pfenex Losing Two Execs From Its C-Suite

Public drugmaker Pfenex Inc. is losing two of its top executives: Chief Financial Officer Paul Wagner and Chief Manufacturing Officer Steve Sandoval.

Co. Finds Influential Niche in High-End Workout Apparel

RETAIL: Founders Use Storefront to Test Designs

Graced by Grit has eight full-time employees, but hundreds of social-media influencers regularly showcase its high-end athletic wear for women online.

Tease photo

MEI Pharma Buys Exclusive Global Rights to Anti-Cancer Drug

Local drugmaker MEI Pharma has agreed to pay $2.9 million upfront to Presage Biosciences for exclusive global rights to a potential new drug.

Bankruptcy Court approves Sempra’s Oncor Deal

Sempra Energy’s $9.45 billion deal to obtain ownership interest in Texas energy giant Oncor Electric took a step forward on Wednesday.

Likely Last Drug From Ardea Biosciences Approved for Sale

Ardea Biosciences, the local biotech now owned by AstraZeneca, got the green light from regulators to sell a new drug developed in San Diego labs. It’s the second medicine to make it from Ardea’s labs to the market, and will likely be the last.

Modern Times Beer Opening New Portland Facilities in 2018

San Diego’s Modern Times Beer will be expanding into Portland, Ore., in early 2018, as the Point Loma-based brewer continues to grow its operations footprint beyond San Diego County.

Tease photo

FDA Approves Tandem’s Latest Insulin Pump With Dexcom Technology

San Diego medical device company Tandem Diabetes Care announced FDA approval and the launch of a new touchscreen insulin pump with continuous glucose monitoring from Dexcom, another local company.

New Drug Application Acceptance Gives La Jolla Pharmaceutical Some Momentum in the Market

La Jolla Pharmaceutical Co.'s stock is climbing following good news from regulators.

Sempra Does Its Homework for Oncor Deal

It Studied Failure of Past Efforts To Purchase Oncor